Clinical Trial Update: Iberdomide, Daratumumab, Bortezomib, and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma, IDEAL Study [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes an ongoing Phase 1/2 study evaluating a quadruplet regimen of Iberdomide, daratumumab, bortezomib, and dexamethasone for ne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DARZALEX (daratumumab)
• Decadron (Dexamethasone)
• Velcade (bortezomib)
• iberdomide (iberdomide)

Snippet

Sponsor: Mayo Clinic | Conditions: Plasma Cell Myeloma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING